Company Reports

Recent Updates

All Reports

Company Report

While its primary business is insurance, Fairfax is in some ways more of an investment fund. Chair and CEO Prem Watsa has a long history of bold investment bets and has shown a willingness to be unorthodox in portfolio construction. We're somewhat skeptical of this approach, as we believe disciplined underwriting is a more reliable path to long-term value creation for insurers. Fairfax's underwriting record is relatively poor, although it has improved recently amid a hard market.
Company Report

While its primary business is insurance, Fairfax is in some ways more of an investment fund. Chair and CEO Prem Watsa has a long history of bold investment bets and has shown a willingness to be unorthodox when it comes to portfolio construction. We're somewhat skeptical of this approach, as we believe disciplined underwriting is a more reliable path to long-term value creation for insurers. Fairfax's underwriting record is relatively poor, although it has improved recently.
Company Report

While its primary business is insurance, Fairfax is in some ways more of an investment fund. Chair and CEO Prem Watsa has a long history of bold investment bets and has shown a willingness to be unorthodox when it comes to portfolio construction. We're somewhat skeptical of this approach, as we believe disciplined underwriting is a more reliable path to long-term value creation for insurers. Fairfax's underwriting record is relatively poor, although it has improved recently.
Company Report

While its primary business is insurance, Fairfax is in some ways more of an investment fund. Chair and CEO Prem Watsa has a long history of bold investment bets and has shown a willingness to be unorthodox when it comes to portfolio construction. As a result, compared with other insurers, the company's results tend to be much more driven by results on the investment side. We're somewhat skeptical of this approach, as we believe disciplined underwriting is a more reliable path to long-term value creation for insurers. Fairfax's underwriting record is relatively poor, although it has improved recently.
Company Report

While its primary business is insurance, Fairfax is in some ways more of an investment fund. Chair and CEO Prem Watsa has a long history of bold investment bets and has shown a willingness to be unorthodox when it comes to portfolio construction. As a result, compared with other insurers, the company's results tend to be much more driven by results on the investment side. We're somewhat skeptical of this approach, as we believe disciplined underwriting is a more reliable path to long-term value creation for insurers. Fairfax's underwriting record is relatively poor, although it has improved recently.
Company Report

While its primary business is insurance, Fairfax is in some ways more of an investment fund. Chair and CEO Prem Watsa has a long history of bold investment bets and has shown a willingness to be unorthodox when it comes to portfolio construction. As a result, compared with other insurers, the company's results tend to be much more driven by results on the investment side. We're somewhat skeptical of this approach, as we believe disciplined underwriting is a more reliable path to long-term value creation for insurers. Fairfax's underwriting record is relatively poor, although it has improved recently.
Stock Analyst Note

Like its peers, Fairfax is enjoying multiple tailwinds at the moment that are driving strong performance. For the full year, book value per share, adjusted for dividends, grew 14.5%. We will maintain our CAD 1,290 fair value estimate for the no-moat company and see shares as materially overvalued. We think the market is overly focused on the positive near-term picture for Fairfax and its P&C insurance peers and not fully factoring in the fact that returns will ultimately normalize. We think this is especially true for Fairfax, given that it has had some additional positives recently.
Stock Analyst Note

Fairfax’s third-quarter results were positively impacted by a $1.3 billion gain on investments, which drove net income of $1.0 billion for the quarter. But even putting this aside, results looked strong. Fairfax, like its peers, is currently enjoying tailwinds on both sides of the business as underwriting conditions remain favorable and higher interest rates boost investment income. Adjusted for dividends, book value per share has increased 12% since the end of 2023. We will maintain our fair value estimate for the no-moat company and see the shares as materially overvalued. We believe the market is overly focused on near-term results, and we expect returns to normalize over time.
Company Report

While its primary business is insurance, Fairfax is in some ways more of an investment fund. Chairman and CEO Prem Watsa has a long history of bold investment bets and has shown a willingness to be unorthodox when it comes to portfolio construction. As a result, compared with other insurers, the company's results tend to be driven more by results on the investment side. We're somewhat skeptical of this approach, as we believe disciplined underwriting is a more reliable path to long-term value creation for insurers. Fairfax's underwriting record is relatively poor, although it has improved recently.
Stock Analyst Note

Fairfax enjoyed a strong second quarter, as it is benefiting from favorable industry underwriting conditions and seeing some tailwinds on the investment side. Book value per share, adjusted for dividends, is up 6% from year-end. We think the near-term outlook for the company is bright, but we also believe that insurance is a highly competitive and inherently mean-reverting industry, and that current tailwinds will dissipate. We will maintain our CAD 1,180 fair value estimate for the no-moat company. We see shares as overvalued and think the market is overly focused on the company’s near-term prospects.
Stock Analyst Note

We think Fairfax’s first-quarter results were solid. Underwriting margins held at an attractive level, and tailwinds continue on the investing side. Book value per share, adjusted for dividends, increased 2% from year-end. We will maintain our CAD 1,180 fair value estimate and no-moat rating. We continue to see shares as overvalued. While Fairfax is performing well right now, its historical record is mixed, and we think the market is overly focused on the favorable near-term outlook.
Stock Analyst Note

We are increasing our fair value estimate for Fairfax to CAD 1,180 per share from CAD 970 after reassessing the company's prospects on the investment side given recent changes in capital market conditions. Our fair value estimate equates to 1.0 times year-end 2023 book value and 1.4 times tangible book value. We still see the shares as materially overvalued from a long-term perspective. While the company is navigating the current capital market environment well, we would note that Fairfax's investment performance has been spotty over time. Although the company is riding high at the moment, its historical track record includes some substantial losses along with impressive gains.
Company Report

While its primary business is insurance, Fairfax is in some ways more of an investment fund. Chairman and CEO Prem Watsa has a long history of bold investment bets and has shown a willingness to be unorthodox when it comes to portfolio construction. As a result, compared with other insurers, the company's results tend to be driven more by results on the investment side. We're somewhat skeptical of this approach, as we believe disciplined underwriting is a more reliable path to long-term value creation for insurers, and Fairfax's underwriting record is relatively poor.

Sponsor Center